MedTrace Logo

Zinc Supplementation Effect on Immune Recovery in HIV Patients

NCT02162797 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-06-13

No results posted yet for this study

Summary

INTRODUCTION:

An adequate zinc supplementation is essential for a good immunological function. However, zinc deficiency is seen in more than 50% of adults infected with HIV. The safety and efficiency of zinc supplements in the progression of HIV is evaluated in the short-term.

HYPOTHESIS

Null hypothesis: Zinc supplementation does not improve the immunological recovery of HIV patients after three months of daily consumption.

Alternate hypothesis: Zinc supplementation improves the immunological recovery of HIV patients after three months of daily consumption

Conditions

  • HIV
  • AIDS
  • Immunological Deficiency
  • Inadequate Immune Recovery
  • Viral Replication

Interventions

DIETARY_SUPPLEMENT

Zinc supplementation

Intervention group A: Patients who will orally receive zinc for 3 months.

DIETARY_SUPPLEMENT

Placebo supplementation

Intervention Group B: Patients who will orally receive a placebo for 3 months.

Sponsors & Collaborators

  • IPS Fundación SIAM

    collaborator UNKNOWN

  • CES University

    lead OTHER

Principal Investigators

  • Heidy Contreras, PhC. · Researcher

  • Marcela Duque, MD. · Researcher

  • Elsa Vásquez, Biologist · Researcher

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162797 on ClinicalTrials.gov